Addressing Antimicrobial Resistance—The Invisible Pandemic | Health Affairs Blog
As cases of COVID-19 begin to recede, health officials will need to shift gears to address the pandemic lying in wait: antimicrobial resistance (AMR). In this blog post, we outline how the operational and regulatory structures developed during COVID-19 represent a scalable model to accelerate biomedical innovation for AMR.